Otros idiomas MAIA Biotechnology, Inc.

Acciones

MAIA

US5526411021

Mercado cerrado - Nyse Otros sitios de cotización 22:00:00 28/06/2024			Varia. Cinco días.	Varia. 1 de enero.
3,42 ^USD	+2,70 %		+8,57 %	+192,31 %

07/06	La función telomérica de MAIA Biotechnology se demuestra viable con la aprobación por la FDA de una terapia con un agente inhibidor de la telomerasa	CI
04/06	Maia Biotechnology revela nuevos datos clínicos que demuestran la gran eficacia de THIO en el cáncer de pulmón no microcítico	CI

Otros idiomas

Desbloquee todas las noticias: ¡Sea el primero en enterarse y reaccione antes que los mercados!

Inscripción 100% Gratuita

Pioneering Cancer Treatment: the Successful Partnership Between MAIA Biotechnology and Cromos Pharma	22/06
MAIA Biotechnology Shares Rise After FDA's Telomerase Inhibitor Approval Shows Viability of Such Therapies	07/06
MAIA Biotechnology's Telomere Targeting Functionality is Shown Viable by FDA’s Approval of a Telomerase Inhibitor Agent Therapy	07/06
MAIA Biotechnology's Telomere Targeting Functionality is Shown Viable by FDA?s Approval of a Telomerase Inhibitor Agent Therapy	07/06
MAIA Biotechnology Announces Year-to-Date Achievements and Highlights Recent Clinical Progress for Novel Anticancer Agent	06/06
Groundbreaking Study by MAIA Biotechnology (NYSE: MAIA) Indicates Promising New Treatment for Advanced Lung Cancer	06/06
MAIA BIOTECHNOLOGY REVEALS NEW CLINICAL DATA SHOWING THIO'S STRONG EFFICACY IN NON-SMALL CELL LUNG CANCER	05/06
MAIA Biotechnology Reveals New Clinical Data Showing THIO’s Strong Efficacy in Non-Small Cell Lung Cancer	04/06
Maia Biotechnology Reveals New Clinical Data Showing Thio?s Strong Efficacy in Non-Small Cell Lung Cancer	04/06
MAIA Biotechnology : Poster (June 2024)	03/06
MAIA Biotechnology (NYSE: MAIA) Makes Strategic Moves: Key Presentations, New Funding, and Leadership Changes Drive Innovation	21/05
MAIA Biotechnology, Inc. announced a financing transaction	21/05
MAIA BIOTECHNOLOGY TO PRESENT AT THE BIO INTERNATIONAL CONVENTION 2024	20/05
MAIA BIOTECHNOLOGY ABSTRACT ACCEPTED FOR POSTER PRESENTATION AT AMERICAN SOCIETY OF CLINICAL ONCOLOGY 2024 ANNUAL MEETING	17/05
MAIA Biotechnology to Present at the BIO International Convention 2024	17/05
MAIA Biotechnology Abstract Accepted for Poster Presentation at American Society of Clinical Oncology (ASCO) 2024 Annual Meeting	16/05
MAIA Biotechnology, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	14/05
MAIA Biotechnology Announces Share Purchase by Director Adelina Louie in Private Placement	30/04
MAIA Biotechnology Announces Share Purchase by Director Stan Smith, Ph.D. in Private Placement	29/04
Maia Biotechnology Insider Bought Shares Worth $299,409, According to a Recent SEC Filing	26/04

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas MAIA Biotechnology, Inc.

Acciones

MAIA

US5526411021

Otros idiomas

Filtros